NovaBay Pharmaceuticals Stock Target Price and Analyst Consensus

NBY Stock  USD 0.09  0.0003  0.34%   
The current analyst and expert consensus on NovaBay Pharmaceuticals is Strong Buy, with 2 strong buy opinions. The current projected NovaBay Pharmaceuticals target price consensus is 6.65 with 2 analyst opinions. The most common way NovaBay Pharmaceuticals analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview NovaBay Pharmaceuticals executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on NovaBay Pharmaceuticals. We encourage you to use your own analysis of NovaBay Pharmaceuticals to validate this buy or sell advice. NovaBay Pharmaceuticals buy-or-sell recommendation module provides average expert sentiment on the projected NovaBay Pharmaceuticals target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on NovaBay Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more information on how to buy NovaBay Stock please use our How to Invest in NovaBay Pharmaceuticals guide.
Lowest Forecast
6.05
Highest Forecast
7.38
Target Price
6.65
At this time, NovaBay Pharmaceuticals' Gross Profit is fairly stable compared to the past year. Gross Profit Margin is likely to rise to 0.80 in 2024, whereas Pretax Profit Margin is likely to drop (0.69) in 2024. At this time, NovaBay Pharmaceuticals' Other Liabilities is fairly stable compared to the past year. Current Deferred Revenue is likely to rise to about 1.2 M in 2024, whereas Other Assets are likely to drop slightly above 461.6 K in 2024.
  
It's important to approach NovaBay Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize NovaBay Pharmaceuticals price targets

NovaBay Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using NovaBay Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at NovaBay Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if NovaBay Pharmaceuticals' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional NovaBay Pharmaceuticals Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of NovaBay Pharmaceuticals is a key component of NovaBay Pharmaceuticals valuation and have some predictive power on the future returns of a NovaBay Pharmaceuticals.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NovaBay Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.085.43
Details
Intrinsic
Valuation
LowRealHigh
0.091.737.08
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.25-0.15-0.05
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as NovaBay Pharmaceuticals. Your research has to be compared to or analyzed against NovaBay Pharmaceuticals' peers to derive any actionable benefits. When done correctly, NovaBay Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in NovaBay Pharmaceuticals.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
ESG Investing Idea
ESG Investing
Invested few shares
Corona Opportunity Idea
Corona Opportunity
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 100 shares
Momentum Idea
Momentum
Invested over 200 shares
Investor Favorites Idea
Investor Favorites
Invested over 70 shares
Banking Idea
Banking
Invested over 30 shares
When determining whether NovaBay Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NovaBay Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Novabay Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Novabay Pharmaceuticals Stock:
Check out Macroaxis Advice on NovaBay Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more information on how to buy NovaBay Stock please use our How to Invest in NovaBay Pharmaceuticals guide.
Note that the NovaBay Pharmaceuticals information on this page should be used as a complementary analysis to other NovaBay Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for NovaBay Stock analysis

When running NovaBay Pharmaceuticals' price analysis, check to measure NovaBay Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovaBay Pharmaceuticals is operating at the current time. Most of NovaBay Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NovaBay Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovaBay Pharmaceuticals' price. Additionally, you may evaluate how the addition of NovaBay Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
The data published in NovaBay Pharmaceuticals' official financial statements usually reflect NovaBay Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of NovaBay Pharmaceuticals. For example, before you start analyzing numbers published by NovaBay accountants, it's critical to develop an understanding of what NovaBay Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of NovaBay Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, NovaBay Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in NovaBay Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of NovaBay Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of NovaBay Pharmaceuticals' management manipulating its earnings.